Do I Qualify?
Jeff Kozloff's avatarPerson

Jeff Kozloff

CEOTrialScope

Philadelphia Area

Member Since May 2019

About

Jeff Kozloff is a serial healthcare entrepreneur with over 18 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the company’s board of directors for more than two years. Prior to TrialScope, he was the founder of two successful healthcare technology companies, HeroLinx and Verilogue. HeroLinx is an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global leader in the capture and linguistic analysis of physician-patient exam room dialogues. He also previously served on the board of directors for iContracts, a SaaS compliance and revenue management company, and he remains an active angel investor and advisor to a half-dozen software and analytics companies. He holds a bachelor's degree in economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.

Published content

Five Reasons Why Transparency Is Good Business

article

All companies, regardless of the industry, should revisit their commitments to transparency.

Clinical Research: Aiding The Advancement Of Science And The U.S. Economy

article

It's up to leaders in healthcare and technology to make clinical trials more accessible.

Awareness, Access And Eligibility: Using Technology To Achieve The Triple Aim Of Clinical Trial Recruitment

article

Three primary barriers still stand in the way of study participation, but simple adjustments to the way sponsors use technology can help improve access and achieve better outcomes.

Company details

TrialScope

Company bio

TrialScope simplifies the complexities of clinical trial transparency. Our award-winning, proven solutions have been implemented successfully and rigorously tested in the most complex environments and are managing disclosures for sponsors that are responsible for over 35% of industry-sponsored clinical trials posted on clinicaltrials.gov. The company’s market-driven solutions and expertise enable sponsors to improve performance, mitigate compliance risk, and ultimately optimize efficiencies with clinical content lifecycle management tools, expertise, and processes. TrialScope technologies are offered via a validation-ready SaaS platform hosted in a private cloud.

Industry

Computer Software

This member is no longer active.

Interested in expanding your professional network and getting published on Forbes.com?

Click below to learn more about membership and publication opportunities.
Get PublishedExplore Forbes Councils
Forbes Councils is a vetted professional organization where top CEOs and entrepreneurs across industries make connections, grow their businesses and get visibility on Forbes.com.